Institute for Translational Research

Organization profile

Organization profile

The Institute for Translational Sciences (ITS) aims to train a new generation of clinical and translational researchers, engage stakeholders and communities in research, address barriers to clinical and translational research, and advance translational research through team-based approaches. The ITS, established in 2007, is the academic home of UTMB’s Clinical Translational Sciences Award (CTSA), funded by the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS). CTSA institutions work together to speed the translation of research discoveries into improved health. 

David Urban, Director

Fingerprint Dive into the research topics where Institute for Translational Research is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Respiratory Syncytial Viruses Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Respiratory Syncytial Virus Infections Medicine & Life Sciences
Attenuated Vaccines Medicine & Life Sciences
Epithelial Cells Medicine & Life Sciences
Proteins Medicine & Life Sciences
Cyclin-Dependent Kinase 9 Medicine & Life Sciences
Viruses Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2024

Research Output 1994 2019

AGS and NIA Bench-to Bedside Conference Summary: Osteoporosis and Soft Tissue (Muscle and Fat) Disorders

Colón-Emeric, C., Whitson, H. E., Berry, S. D., Fielding, R. A., Houston, D. K., Kiel, D. P., Rosen, C. J., Seldeen, K. L., Volpi, E., White, J. P. & Troen, B. R., Jan 1 2019, (Accepted/In press) In : Journal of the American Geriatrics Society.

Research output: Contribution to journalArticle

Open Access
Sarcopenia
Muscular Diseases
Osteoporosis
Fats
Quality of Life

An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses

Li, G., Adam, A., Luo, H., Shan, C., Cao, Z., Fontes-Garfias, C. R., Sarathy, V. V., Teleki, C., Winkelmann, E. R., Liang, Y., Sun, J., Bourne, N., Barrett, A. D. T., Shi, P. Y. & Wang, T., Dec 1 2019, In : npj Vaccines. 4, 1, 48.

Research output: Contribution to journalArticle

Open Access
Mutant Proteins
Antiviral Agents
Attenuated Vaccines
Flavivirus
Zika Virus
2 Citations (Scopus)
Open Access
Clinical Trials, Phase I
Geriatrics
Hospitalization
Randomized Controlled Trials
Placebos

Prizes

Scholar, Translational Research Scholar Program

Tomoko Makishima (Recipient), Aug 2010

Prize: Other distinction